Evidence map›Paper›PMID 28490770›Full record

SynthesisScientific reports2017

Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis.

Hang-Lin Wu, Sheeba Marwah, Pei Wang, Qiu-Meng Wang, Xiao-Wen Chen

Registry-linked trialOpen access · goldAbstract readSystematic ReviewNetwork Meta-Analysis
In one paragraph

Synthesis in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04579965 (Misotac vs Combined Oral Contraceptive Pill in the Treatment of Symptomatic Isthmocele), which is not on this map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04579965 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Misotac vs Combined Oral Contraceptive Pill in the Treatment of Symptomatic Isthmocele

TypeinterventionalSponsorMansoura University HospitalRan2020 to 2021Enrolled50ConditionsDysfunctional Uterine BleedingArmsmedical treatment of isthmocele
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Off-label use of medicines in South Africa: a review.Orphanet journal of rare diseases · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Hang-Lin WuDepartment of Obstetrics and Gynaecology, Hangzhou Women's Hospital, Hangzhou, 310008, Zhejiang, China. hanglinwu@gmail.com.ORCID 0000-0001-7882-3072
Sheeba MarwahDepartment of Obstetrics and Gynaecology, VMMC and Safdarjung Hospital, New Delhi, 110029, India.
Pei WangDepartment of Obstetrics and Gynaecology, Hangzhou Women's Hospital, Hangzhou, 310008, Zhejiang, China.
Qiu-Meng WangDepartment of Obstetrics and Gynaecology, Hangzhou Women's Hospital, Hangzhou, 310008, Zhejiang, China.
Xiao-Wen ChenDepartment of Obstetrics and Gynaecology, Hangzhou Women's Hospital, Hangzhou, 310008, Zhejiang, China.
Hangzhou Women’s Hospital · CNSafdarjang Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy and safety of misoprostol alone for missed abortion varied with different regimens. To evaluate existing evidence for the medical management of missed abortion using misoprostol, we undertook a comprehensive review and meta-analysis. The electronic literature search was conducted using PubMed, the Cochrane Library, Embase, EBSCOhost Online Research Databases, Springer Link, ScienceDirect, Web of Science, Ovid Medline and Google Scholar. 18 studies of 1802 participants were included in our analysis. Compared with vaginal misoprostol of 800 ug or sublingual misoprostol of 600 ug, lower-dose regimens (200 ug or 400 ug) by any route of administration tend to be significantly less effective in producing abortion within about 24 hours. In terms of efficacy, the most effective treatment was sublingual misoprostol of 600 ug and the least effective was oral misoprostol of 400 ug. In terms of tolerability, vaginal misoprostol of 400 ug was reported with fewer side effects and sublingual misoprostol of 600 ug was reported with more side effects. Misoprostol is a non-invasive, effective medical method for completion of abortion in missed abortion. Sublingual misoprostol of 600 ug or vaginal misoprostol of 800 ug may be a good choice for the first dose. The ideal dose and medication interval of misoprostol however needs to be further researched.

Indexed as

Abortion, MissedFemaleHumansMisoprostolPregnancyMisoprostol

Identifiers

PMID28490770
PMCPMC5431938
OpenAlexW2611408882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.